|
Company Warned for Noncompliance on Clinical Trial Protocol, Protections
The FDA handed Atlanta-based CardioMEMS a warning letter for numerous deviations related to a clinical investigation and PMA for its CardioMEMS HF Pressure Measurement System.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives